1. Signaling Pathways
  2. Anti-infection
  3. HIV
  4. HIV Isoform



HIV Related Products (336):

Cat. No. Product Name Effect Purity
  • HY-90006
    Inhibitor 99.86%
    5-Fluorouracil (5-FU) is an analogue of uracil and a potent antitumor agent.
  • HY-16591
    Inhibitor 99.70%
    Birinapant (TL32711), a bivalent Smac mimetic, is a potent antagonist for XIAP and cIAP1 with Kds of 45 nM and less than 1 nM, respectively.
  • HY-B0545
    Inhibitor 99.95%
    Probenecid is a potent and selective agonist of transient receptor potential vanilloid 2 (TRPV2) channels.
  • HY-17363
    Dimethyl fumarate
    Inhibitor 99.91%
    Dimethyl fumarate (DMF) is an orally active and brain-penetrant Nrf2 activator and induces upregulation of antioxidant gene expression.
  • HY-90001
    Inhibitor 99.81%
    Ritonavir (ABT 538) is an inhibitor of HIV protease used to treat HIV infection and AIDS.
  • HY-P1102
    Inhibitor 99.43%
    TC14012, a serum-stable derivative of T140, is a selective and peptidomimetic CXCR4 antagonist with an IC50 of 19.3 nM.
  • HY-P1104A
    FC131 TFA
    Inhibitor 98.38%
    FC131 TFA is a CXCR4 antagonist, inhibits [125I]-SDF-1 binding to CXCR4, with an IC50 of 4.5 nM.
  • HY-13750
    Inhibitor 99.58%
    Ebselen (SPI-1005), a glutathione peroxidase mimetic, is a potent voltage-dependent calcium channel (VDCC) blocker.
  • HY-16900
    Inhibitor 99.58%
    Rolipram is a selective phosphodiesterases PDE4 inhibitor with IC50s of 3 nM, 130 nM and 240 nM for PDE4A, PDE4B, and PDE4D, respectively.
  • HY-12519
    Inhibitor 99.74%
    Oltipraz has an inhibitory effect on HIF-1α activation in a time-dependent manner, completely abrogating HIF-1α induction at ≥10 μM concentrations, the IC50 of Oltipraz for HIF-1α inhibition is 10 μM.
  • HY-B0250
    Inhibitor 99.85%
    Lamivudine (BCH-189) is an orally active nucleoside reverse transcriptase inhibitor (NRTI).
  • HY-W013332A
    3-Deazaadenosine hydrochloride
    Inhibitor 99.44%
    3-Deazaadenosine (hydrochloride) is an inhibitor of S-adenosylhomocysteine hydrolase, with a Ki of 3.9 µM; 3-Deazaadenosine has anti-inflammatory, anti-proliferative and anti-HIV activity.
  • HY-13238
    Inhibitor 99.65%
    Dolutegravir (S/GSK1349572) is a highly potent and orally bioavailable HIV integrase strand transfer inhibitor with an IC50 of 2.7 nM for HIV-1 integrase-catalyzed strand transfer.
  • HY-N0156
    Oleanolic Acid
    Inhibitor ≥98.0%
    Oleanolic acid (Caryophyllin) is a natural compound from plants with anti-tumor activities.
  • HY-B2237
    Lysozyme from chicken egg white
    Lysozyme from chicken egg white is a bactericidal enzyme, and it lyses gram-positive bacteria.
  • HY-17605
    Inhibitor 99.79%
    Bictegravir (GS-9883) is a potent inhibitor of HIV-1 integrase with an IC50 of 7.5 nM.
  • HY-10052
    Inhibitor 99.67%
    Aprepitant (MK-0869) is a selective and high-affinity neurokinin 1 receptor antagonist with a Kd of 86 pM.
  • HY-17007
    Inhibitor 99.73%
    Saquinavir(Ro 31-8959) is an HIV Protease inhibitor used in antiretroviral therapy.
  • HY-10353
    Inhibitor 99.53%
    Raltegravir is a potent integrase (IN) inhibitor, used to treat HIV infection.
  • HY-15601
    Inhibitor 99.90%
    Vesatolimod (GS-9620) is a potent, selective and orally active agonist of Toll-Like Receptor (TLR7) with an EC50 of 291 nM.